Obinutuzumab in the treatment of life threatening ANCA-associated vasculitis

Authors
Category Primary study
ConferenceCase-based Conference 2025
Year 2025
This article has no abstract
Epistemonikos ID: 62e25f0ac0f8d8b4860fe4cff1fef117f6b2b2b1
First added on: Dec 12, 2025